表紙
市場調查報告書
商品編碼
971912

全球乳癌治療藥的市場規模調查:各產品,各流通管道,及各地區預測(2020年∼2027年)

Global Breast Cancer Therapeutics Market Size study, By Product, By Distribution Channel, and Regional Forecasts 2020-2027

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球乳癌治療藥的市場規模在2019年估算為約195億7000萬美元,在2020年∼2027年的預測期間內,預計將以超越10.16%的成長率增長。由於過度暴露於內源性雌激素,月經過早,分娩晚和絕經晚等因素,導致乳腺癌的發病率上升對產業的發展產生了重大影響。癌症生物學技術的發展以及全球診斷和篩查計劃的推出有望推動產業發展。通過諸如阻斷雌激素與腫瘤細胞的結合,遠距離復發的風險,降低乳房因腫瘤復發的風險以及降低疾病發展的風險等因素,越來越多的治療藥物被接受,從而刺激了行業的發展。在預測期內,由於酒精攝入量增加,雌激素替代療法(HRT)的使用增加以及女性口服避孕藥的使用增加,雌激素水平增加,這將增加市場的規模。但是,與使用乳腺癌治療相關的高昂成本會阻礙該行業的發展。

本報告提供乳癌治療藥市場調查,提供市場概要,市場成長要素及阻礙因素分析,各產品,各流通管道,各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄

第1章 摘要整理

第2章 全球乳癌治療藥市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 產業的演進
  • 調查對象年度
  • 匯率

第3章 全球乳癌治療藥市場動態

  • 乳癌治療藥市場影響分析

第4章 全球乳癌治療藥市場:產業分析

  • 波特五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 全球乳癌治療藥市場:各產品

  • 市場概述
  • 全球乳癌治療藥市場-潛在性分析
  • 全球乳癌治療藥市場:估計與各產品預測
  • 乳癌治療藥市場:子區隔分析
    • 荷爾蒙劑
    • 化療藥
    • 標的藥物療法

第6章 全球乳癌治療藥市場:各流通管道

  • 市場概述
  • 全球乳癌治療藥市場-潛在性分析
  • 全球乳癌治療藥市場:估計與預測
  • 乳癌治療藥市場:子區隔分析
    • 醫院
    • 門診病人手術中心
    • 診所
    • 電子商務
    • 零售藥局

第7章 全球乳癌治療藥市場:各地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第8章 競爭資訊

  • 首位市場策略
  • 企業簡介
    • AstraZeneca
    • Bristol-Myers Squibb
    • Eisai Co. Ltd
    • Eli Lilly and Company
    • Genentech
    • GlaxoSmithKline
    • Halozyme Inc.
    • Novartis AG
    • Pfizer Inc.
    • Genzyme Corporation

第9章 調查流程

目錄

Title:
Global Breast Cancer Therapeutics Market Size study, By Product (Hormone Drugs, Chemotherapy Drugs, Targeted Drug Therapy), By Distribution Channel (Hospitals, Ambulatory Surgical Centers, Clinics, e-commerce, Retail Pharmacies), and Regional Forecasts 2020-2027.

Global Breast Cancer Therapeutics Market is valued approximately at USD 19.57 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 10.16% over the forecast period 2020-2027. Growing incidence of breast cancer due to factors such as excessive exposure to endogenous estrogens, early menarche, late birth and late menopause would have a high effect on the growth of the industry. The technical developments in cancer biology and the introduction of a range of diagnostic and screening programs around the world should drive the company. Growing acceptance of therapeutic drugs due to factors such as the blocking of estrogen from binding to tumor cells, the risk of distant reappearance, the lowering of the risk of reappearance in the breast that had tumor, and the lowering of the risk of developing disease in another breast would stimulate the growth of the industry. The awareness of breast cancer, a growing change towards western lifestyle adoption, a limited breast-feeding period and a growing prevalence of obesity in postmenopausal women would drive industry size. Increased intake of alcohol in women, increased use of hormone replacement therapy (HRT) and oral birth control pills resulting in increased levels of estrogen would increase the size of the company over the forecast period. Growing exposure to certain carcinogens and endocrine disruptors, for example, in the workplace, night shifts result in increased risk, and the global demand is increasing. WHO has reported that breast cancer affects around 2.1 million people per year and is the leading cause of malignancy-related deaths. In 2018, 627,000 women were estimated to have died of breast cancer globally, accounting for 15 % of total deaths. Prohibitive costs associated with the use of breast cancer therapy can impede the growth of the industry. Increasing the cost of early and late-stage disease treatment, continuing care on a per-unit basis, accounting for a significant share of lifetime costs due to the relatively longer survival of breast cancer patients, may further restrict business growth.

The regional analysis of global Breast Cancer Therapeutics Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is anticipated to account for the largest market share in 2018. Development is due to a growing incidence of breast cancer and increased support for R&D across the public and private sectors. Growing elderly population, early-onset breastfeeding and expanded access to cancer care would stimulate industry development. In addition, growing demand for tumor therapy would strongly boost the growth of the industry in the region.

Major market player included in this report are:

  • AstraZeneca
  • Bristol-Myers Squibb
  • Eisai Co. Ltd
  • Eli Lilly and Company
  • Genentech
  • GlaxoSmithKline
  • Halozyme Inc.
  • Novartis AG
  • Pfizer Inc.
  • Genzyme Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Hormone Drugs
  • Chemotherapy Drugs
  • Targeted Drug Therapy

By Distribution Channel:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • e-commerce
  • Retail Pharmacies

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2017, 2018
  • Base year - 2019
  • Forecast period - 2020 to 2027

Target Audience of the Global Breast Cancer Therapeutics Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Breast Cancer Therapeutics Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Breast Cancer Therapeutics Market, by Product, 2018-2027 (USD Billion)
    • 1.2.3. Breast Cancer Therapeutics Market, by Distribution Channel, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Breast Cancer Therapeutics Market Definition & Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Breast Cancer Therapeutics Market Dynamics

  • 3.1. Breast Cancer Therapeutics Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Breast Cancer Therapeutics Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Breast Cancer Therapeutics Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Breast Cancer Therapeutics Market by Product, Performance - Potential Analysis
  • 5.3. Global Breast Cancer Therapeutics Market Estimates & Forecasts by Product, 2017-2027 (USD Billion)
  • 5.4. Breast Cancer Therapeutics Market, Sub Segment Analysis
    • 5.4.1. Hormone Drugs
    • 5.4.2. Chemotherapy Drugs
    • 5.4.3. Targeted Drug Therapy

Chapter 6. Global Breast Cancer Therapeutics Market, by Distribution Channel

  • 6.1. Market Snapshot
  • 6.2. Global Breast Cancer Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 6.3. Global Breast Cancer Therapeutics Market Estimates & Forecasts by Distribution Channel, 2017-2027 (USD Billion)
  • 6.4. Breast Cancer Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centres
    • 6.4.3. Clinics
    • 6.4.4. e-commerce
    • 6.4.5. Retail Pharmacies

Chapter 7. Global Breast Cancer Therapeutics Market, Regional Analysis

  • 7.1. Breast Cancer Therapeutics Market, Regional Market Snapshot
  • 7.2. North America Breast Cancer Therapeutics Market
    • 7.2.1. U.S. Breast Cancer Therapeutics Market
      • 7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Breast Cancer Therapeutics Market
  • 7.3. Europe Breast Cancer Therapeutics Market Snapshot
    • 7.3.1. U.K. Breast Cancer Therapeutics Market
    • 7.3.2. Germany Breast Cancer Therapeutics Market
    • 7.3.3. France Breast Cancer Therapeutics Market
    • 7.3.4. Spain Breast Cancer Therapeutics Market
    • 7.3.5. Italy Breast Cancer Therapeutics Market
    • 7.3.6. Rest of Europe Breast Cancer Therapeutics Market
  • 7.4. Asia-Pacific Breast Cancer Therapeutics Market Snapshot
    • 7.4.1. China Breast Cancer Therapeutics Market
    • 7.4.2. India Breast Cancer Therapeutics Market
    • 7.4.3. Japan Breast Cancer Therapeutics Market
    • 7.4.4. Australia Breast Cancer Therapeutics Market
    • 7.4.5. South Korea Breast Cancer Therapeutics Market
    • 7.4.6. Rest of Asia Pacific Breast Cancer Therapeutics Market
  • 7.5. Latin America Breast Cancer Therapeutics Market Snapshot
    • 7.5.1. Brazil Breast Cancer Therapeutics Market
    • 7.5.2. Mexico Breast Cancer Therapeutics Market
  • 7.6. Rest of The World Breast Cancer Therapeutics Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. AstraZeneca
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Industry Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Bristol-Myers Squibb
    • 8.2.3. Eisai Co. Ltd
    • 8.2.4. Eli Lilly and Company
    • 8.2.5. Genentech
    • 8.2.6. GlaxoSmithKline
    • 8.2.7. Halozyme Inc.
    • 8.2.8. Novartis AG
    • 8.2.9. Pfizer Inc.
    • 8.2.10. Genzyme Corporation

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. GLOBAL BREAST CANCER THERAPEUTICS MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD BILLION)
  • TABLE 3. GLOBAL BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2017-2027 (USD BILLION)
  • TABLE 4. GLOBAL BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2017-2027 (USD BILLION)
  • TABLE 5. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 6. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 7. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 8. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 9. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 10. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 11. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 12. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 13. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 14. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 15. U.S. BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 16. U.S. BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 17. U.S. BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 18. CANADA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 19. CANADA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 20. CANADA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 21. UK BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 22. UK BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 23. UK BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 24. GERMANY BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 25. GERMANY BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 26. GERMANY BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 27. ROE BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 28. ROE BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 29. ROE BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 30. CHINA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 31. CHINA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 32. CHINA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 33. INDIA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 34. INDIA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 35. INDIA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 36. JAPAN BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 37. JAPAN BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 38. JAPAN BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 39. ROAPAC BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 40. ROAPAC BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 41. ROAPAC BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 42. BRAZIL BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 43. BRAZIL BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 44. BRAZIL BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 45. MEXICO BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 46. MEXICO BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 47. MEXICO BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 48. ROLA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 49. ROLA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 50. ROLA BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 51. ROW BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS, 2017-2027 (USD BILLION)
  • TABLE 52. ROW BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 53. ROW BREAST CANCER THERAPEUTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD BILLION)
  • TABLE 54. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER THERAPEUTICS MARKET
  • TABLE 55. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BREAST CANCER THERAPEUTICS MARKET
  • TABLE 56. YEARS CONSIDERED FOR THE STUDY
  • TABLE 57. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

  • FIG 1. GLOBAL BREAST CANCER THERAPEUTICS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL BREAST CANCER THERAPEUTICS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL BREAST CANCER THERAPEUTICS MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL BREAST CANCER THERAPEUTICS MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL BREAST CANCER THERAPEUTICS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL BREAST CANCER THERAPEUTICS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL BREAST CANCER THERAPEUTICS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 10. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 11. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 12. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 13. GLOBAL BREAST CANCER THERAPEUTICS MARKET BY SEGMENT, 2017 & 2027 (USD BILLION)
  • FIG 14. GLOBAL BREAST CANCER THERAPEUTICS MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA BREAST CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 16. EUROPE BREAST CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 17. ASIA PACIFIC BREAST CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 18. LATIN AMERICA BREAST CANCER THERAPEUTICS MARKET 2017 & 2027 (USD BILLION)
  • FIG 19. GLOBAL BREAST CANCER THERAPEUTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)